Astrotech Corporation (NASDAQ:ASTC – Get Free Report) was the recipient of a significant growth in short interest in August. As of August 14th, there was short interest totaling 110,734 shares, a growth of 119.7% from the July 30th total of 50,402 shares. Based on an average trading volume of 570,653 shares, the days-to-cover ratio is presently 0.2 days. Approximately 6.3% of the shares of the company are sold short.
Astrotech Price Performance
NASDAQ:ASTC opened at $7.15 on Monday. Astrotech has a one year low of $1.91 and a one year high of $68.85. The company has a market cap of $15.09 million, a P/E ratio of -0.85 and a beta of 4.87. The firm’s fifty day moving average price is $8.56 and its two-hundred day moving average price is $7.95.
Hedge Funds Weigh In On Astrotech
Several institutional investors and hedge funds have recently made changes to their positions in the company. SCS Capital Management LLC bought a new stake in shares of Astrotech in the second quarter valued at about $120,000. Susquehanna International Group LLP bought a new position in Astrotech during the third quarter worth about $66,000. DRW Securities LLC raised its stake in Astrotech by 168.5% in the 4th quarter. DRW Securities LLC now owns 31,464 shares of the aerospace company’s stock worth $109,000 after purchasing an additional 19,747 shares in the last quarter. BlackRock Inc. acquired a new stake in Astrotech in the 2nd quarter worth about $220,000. Finally, J. Safra Sarasin Holding AG bought a new stake in Astrotech in the 1st quarter valued at about $140,000. Institutional investors and hedge funds own 24.35% of the company’s stock.
Analyst Ratings Changes
Check Out Our Latest Report on ASTC
Astrotech Company Profile
Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.
In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.
Featured Stories
- Five stocks we like better than Astrotech
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Receive News & Ratings for Astrotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrotech and related companies with MarketBeat.com's FREE daily email newsletter.
